Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Targeting BMP-1 enhances anti-tumoral effects of doxorubicin in metastatic mammary cancer: common and distinct features of TGF-β inhibition.

Erin N., Tavşan E., Haksever S., Yerlikaya A., Riganti C.
Breast cancer research and treatment , 2025 (SCI-Expanded) identifier

Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC delta and PKC epsilon activators

ERİN N., Tavsan E., Akdeniz O., Isca V. M. S., Rijo P.
CYTOKINE , cilt.142, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences

NİZAM E., KÖKSOY S., ERİN N.
CANCER IMMUNOLOGY IMMUNOTHERAPY , cilt.69, sa.8, ss.1639-1650, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P

NİZAM E., ERİN N.
BIOMEDICINE & PHARMACOTHERAPY , cilt.108, ss.263-270, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists

ERİN N., NIZAM E., TANRIÖVER G., KÖKSOY S.
BREAST CANCER RESEARCH AND TREATMENT , cilt.150, sa.1, ss.57-69, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

Crosstalk Between Schwann Cells and Breast Cancer Cells: Implications for Tumor Progression and Therapeutic Strategies.

Tavşan E., Erin N.
9’th international Congress of the Molecular Biology associaton of Türkiye, İzmir, Türkiye, 12 - 14 Eylül 2024, (Özet Bildiri)

TGF-β1 receptor inhibitor SB-431542 inhibits proliferation of metastatic breast carcinoma cells and enhances anti-tumoral effects of Doxorubicin.

Tavşan E., Shurin G., Shurin M., Erin N.
20’th CIMT Annual Meeting., Mainz, Almanya, 3 - 05 Mayıs 2023

Inhibition of bone morphogenetic protein 1 activity decreases colony and spheroid formation in metastatic breast carcinoma cells

Tavşan E., Erin N.
WG3 Online Meeting, Antalya, Türkiye, 04 Kasım 2020, (Özet Bildiri)

“Effects of neurokinin-2receptor antagonist (GR159897) on metastatic breast cancer cells”

Tavşan E., Ertosun M. G., Erin N.
3rd Anticancer Agent Development Congress, İzmir, Türkiye, 18 - 19 Mayıs 2019, cilt.0, sa.0, ss.1-2, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

Opposed effects of NK1R inhibition on metastatic breast carcinoma; Phenotype-dependent therapeutic and toxic consequences.

Erin N., Tavşan E., Tanrıöver G., Köksoy S.
6th International Conference Cancer Immunotherapy and Immunomonitoring, Tbilisi, Gürcistan, 29 Nisan - 02 Mayıs 2019

Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer.

Tavşan E., Yıldız A. S., Erin N.
6th International Conference Cancer Immunotherapy and Immunomonitoring. , Tbilisi, Gürcistan, 29 Nisan - 02 Mayıs 2019, (Özet Bildiri)

Substance P antagonistlerinin karaciğere metastaz yapmış meme kanseri üzerine İn vivo etkilerinin Araştırılması.

Tavşan E., Tanrıöver G., Erin N.
1.Temel Onkoloji Sempozyumu, İzmir, Türkiye, 9 - 11 Mayıs 2018, (Özet Bildiri)

Protein Kinaz C (PKCε) Aktivatörü FR236924, Meme Kanseri Hücrelerinin Proliferasyonunu Azaltırken Kemokin Sekresyonunu Değiştirmemektedir

Tavşan E., Erin N.
24.Ulusal Farmakoloji Kongresi, Trabzon, Türkiye, 17 - 20 Ekim 2017, (Özet Bildiri)

The effects of PI3K-α and PI3K-β inhibitors on MIP-2 and KC secretion from metastatic breast carcinoma

Tavşan E., Erin N.
6th Multidisciplinary Cancer Research Congress, Konya, Türkiye, 27 - 30 Ekim 2016, (Özet Bildiri)

In-vivo effects of NK1 and NK2 receptor antagonists on metastatic breast carcinoma

Tavşan E., Tanrıöver G., Erin N.
7th European Congress of Pharmacology, İstanbul, Türkiye, 26 - 30 Haziran 2016, (Özet Bildiri)

NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma.

Tavşan E., Erin N.
7th European Congress of Pharmacology, İstanbul, Türkiye, 26 - 30 Haziran 2016, (Özet Bildiri)

Inhibition of PKC activity with Byrostatin alters secretion of inflammatory chemokines.

Erin N., Tavşan E.
14th CIMT Annual Meeting, mechanisms of effıcacy in cancer immunotherapy, Mainz, Almanya, 10 - 12 Mayıs 2016

Effects of neurokinin-1 receptor antagonist (RP67580) on metastatic breast cancer cells

Erin N., Akdeniz Ö., Tavşan E.
EACR- Sponsored 3nd Anticancer Agents Congress , İzmir, Türkiye, 18 - 19 Mayıs 2015

Effects of neurokinin-1 receptor antagonist (RP67580) and neurokinin-2 receptor antagonist (GR159897) on metastatic breast cancer cells

Tavşan E., Erin N.
International Symposium on Advances in Predictive & Personalized Medicine, İstanbul, Türkiye, 2 - 03 Nisan 2015

Phosphatidylinositol 3-kinases are involved in MIP-2 secretion from heart and brain metastatic breast carcinoma.

Tavşan E., Erin N.
EACR- Sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress, Muğla, Türkiye, 23 - 27 Nisan 2014, (Özet Bildiri)
Metrikler

Yayın

22

Atıf (WoS)

25

H-İndeks (WoS)

3

Atıf (Scopus)

63

H-İndeks (Scopus)

4

Proje

14
BM Sürdürülebilir Kalkınma Amaçları